Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Travel Medicine and Infectious Disease|July 18, 2018
Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified casesMatanelle Salama, Ziva Amitai, Yaniv Lustig, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 4, 2011
Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experienceRoberto Hernadez-Alejandro, William Wall, Anthony Jevnikar, et al.
Transplantation|March 21, 1998
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study GroupE Cole, P Keown, D Landsberg, et al.
Canadian Journal of Kidney Health and Disease|May 5, 2021
A Quality Improvement Intervention to Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD) in Patients With Chronic Kidney Disease: Clinical Research Protocol of a Cluster-Randomized Clinical TrialSeychelle Yohanna, Kyla L Naylor, Istvan Mucsi, et al.
Canadian Journal of Kidney Health and Disease|November 28, 2022
Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD): Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical TrialStephanie N Dixon, Kyla L Naylor, Seychelle Yohanna, et al.
Human Molecular Genetics|March 19, 2026
Association of rare apolipoprotein E ε4 homozygosity with an earlier age at onset in spinocerebellar ataxia type 3Charlotte Clara Meyer, Eduardo Preusser de Mattos, Rahel Maria Burger, et al.
Transplantation Direct|February 25, 2025
Feasibility and Optimization of Donation Advisor: a Decision Support Tool for Deceased Organ Donation and TransplantationSonny Dhanani, Rashi Ramchandani, Jill Allan, et al.
JAMA Internal Medicine|November 3, 2023
Effect of a Novel Multicomponent Intervention to Improve Patient Access to Kidney Transplant and Living Kidney Donation: The EnAKT LKD Cluster Randomized Clinical TrialAmit X Garg, Seychelle Yohanna, Kyla L Naylor, et al.
Acta Neuropathologica|August 1, 2024
The parkin V380L variant is a genetic modifier of Machado-Joseph disease with impact on mitophagyJonasz J Weber, Leah Czisch, Priscila Pereira Sena, et al.
Biochemical and Biophysical Research Communications|July 5, 2015
IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancerElise K Heon, Hasi Wulan, Loch P Macdonald, et al.
Pageof 19